Literature DB >> 23787902

Epigenetic silencing of DACH1 induces loss of transforming growth factor-β1 antiproliferative response in human hepatocellular carcinoma.

Hongbin Zhu1, Kongming Wu, Wenji Yan, Ling Hu, Jing Yuan, Yan Dong, Yazhuo Li, Kunyu Jing, Yunsheng Yang, Mingzhou Guo.   

Abstract

UNLABELLED: Human dachshund homolog 1 (DACH1) is a major component of the Retinal Determination Gene Network (RDGN) and functions as a tumor suppressor. However, the regulation of DACH1 expression and its function in hepatocellular carcinoma (HCC) remain unclear. In this study, epigenetic changes of DACH1 were analyzed in HCC cell lines and primary cancers. We found that promoter region hypermethylation was correlated with loss or reduction of DACH1 expression, and restoration of DACH1 expression was induced by 5-aza-2'-deoxycytidine (5-AZA) in HCC cell lines. Promoter region methylation was found in 42% of primary HCC. Reduced expression of DACH1 was associated with poor differentiation of HCC nodules and higher serum aspartate aminotransferase/alanine aminotransferase ratio. DACH1 suppressed cellular growth by reactivating transforming growth factor beta (TGF-β) signaling. Ectopic expression of DACH1 enhanced chemosensitivity to 5-fluorouracil (5-FU) by inducing p21 expression in HCC cells.
CONCLUSION: DACH1 is frequently methylated in HCC and DACH1 expression is regulated by promoter hypermethylation. Down-regulation of DACH1 is a novel mechanism for gaining resistance to the antiproliferative signaling of TGF-β1 and 5-FU resistance.
Copyright © 2013 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23787902     DOI: 10.1002/hep.26587

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  33 in total

1.  Epigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling.

Authors:  Sui Hu; Baoping Cao; Meiying Zhang; Enqiang Linghu; Qimin Zhan; Malcolm V Brock; James G Herman; Gaoping Mao; Mingzhou Guo
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

2.  Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma.

Authors:  Bonan Lin; Xiaomeng Zhou; Shuye Lin; Xiaoyue Wang; Meiying Zhang; Baoping Cao; Yan Dong; Shuai Yang; Ji Ming Wang; Mingzhou Guo; Jiaqiang Huang
Journal:  J Mol Med (Berl)       Date:  2017-08-26       Impact factor: 4.599

Review 3.  Review of Markers of Zona Glomerulosa and Aldosterone-Producing Adenoma Cells.

Authors:  Teresa M Seccia; Brasilina Caroccia; Elise P Gomez-Sanchez; Paul-Emmanuel Vanderriele; Celso E Gomez-Sanchez; Gian Paolo Rossi
Journal:  Hypertension       Date:  2017-09-25       Impact factor: 10.190

4.  DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity.

Authors:  Aili Cao; Jianhua Li; Morad Asadi; John M Basgen; Bingbing Zhu; Zhengzi Yi; Song Jiang; Tomohito Doke; Osama El Shamy; Niralee Patel; Paolo Cravedi; Evren U Azeloglu; Kirk N Campbell; Madhav Menon; Steve Coca; Weijia Zhang; Hao Wang; Ke Zen; Zhihong Liu; Barbara Murphy; John C He; Vivette D D'Agati; Katalin Susztak; Lewis Kaufman
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

5.  SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53.

Authors:  Qi Cheng; Deng Ning; Jin Chen; Xue Li; Xiao-Ping Chen; Li Jiang
Journal:  Cancer Biol Ther       Date:  2018-02-12       Impact factor: 4.742

6.  DACH1, a zona glomerulosa selective gene in the human adrenal, activates transforming growth factor-β signaling and suppresses aldosterone secretion.

Authors:  Junhua Zhou; Lalarukh Haris Shaikh; Sudeshna G Neogi; Ian McFarlane; Wanfeng Zhao; Nichola Figg; Cheryl A Brighton; Carmela Maniero; Ada E D Teo; Elena A B Azizan; Morris J Brown
Journal:  Hypertension       Date:  2015-03-16       Impact factor: 10.190

7.  Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.

Authors:  Xin Li; Jie Yu; Malcolm V Brock; Qian Tao; James G Herman; Ping Liang; Mingzhou Guo
Journal:  Oncotarget       Date:  2015-05-10

8.  RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker.

Authors:  Yongshuai Jin; Baoping Cao; Meiying Zhang; Qimin Zhan; James G Herman; Miao Yu; Mingzhou Guo
Journal:  Genes Cancer       Date:  2015-05

Review 9.  Epigenetic mechanisms in cancer: push and pull between kneaded erasers and fate writers.

Authors:  Ammad Ahmad Farooqi; Jen-Yang Tang; Ruei-Nian Li; Muhammad Ismail; Yung-Ting Chang; Chih-Wen Shu; Shyng-Shiou F Yuan; Jing-Ru Liu; Qaisar Mansoor; Chih-Jen Huang; Hsueh-Wei Chang
Journal:  Int J Nanomedicine       Date:  2015-04-24

10.  MPDZ as a novel epigenetic silenced tumor suppressor inhibits growth and progression of lung cancer through the Hippo-YAP pathway.

Authors:  Wenbin Liu; Yongsheng Huang; Dandan Wang; Fei Han; Hongqiang Chen; Jianping Chen; Xiao Jiang; Jia Cao; Jinyi Liu
Journal:  Oncogene       Date:  2021-06-09       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.